These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7743664)

  • 21. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial peritoneal macrophage function studies in CAPD patients with peritonitis.
    Lin CY; Huang TP
    Adv Perit Dial; 1990; 6():114-9. PubMed ID: 1982786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis.
    Lin CY; Lin CC; Huang TP
    Nephron; 1993; 63(4):404-8. PubMed ID: 8459875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis.
    Fieren MW; van den Bemd GJ; Bonta IL
    Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent transforming growth factor beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Fu LW; Yang LY; Huang TP
    Adv Perit Dial; 1997; 13():64-71. PubMed ID: 9360653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistent transforming growth factor-beta 1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence.
    Lin CY; Chen WP; Yang LY; Chen A; Huang TP
    Am J Nephrol; 1998; 18(6):513-9. PubMed ID: 9845827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of N-methyl-D-aspartate receptor antagonist on T helper cell differentiation induced by phorbol-myristate-acetate and ionomycin.
    Gao M; Jin W; Qian Y; Ji L; Feng G; Sun J
    Cytokine; 2011 Nov; 56(2):458-65. PubMed ID: 21795061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon-gamma levels in peritoneal dialysis effluents: relation to peritonitis.
    Dasgupta MK; Larabie M; Halloran PF
    Kidney Int; 1994 Aug; 46(2):475-81. PubMed ID: 7967361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A low CA++ level in effluent as a risk factor for the peritonitis in CAPD patients.
    Suga H; Honda H; Naganuma S; Yashuo M; Suzuki T; Teraoka S; Agishi T; Ota K
    Adv Perit Dial; 1990; 6():102-5. PubMed ID: 1982783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential induction of T cell cytokine mRNA in Epstein-Barr virus-transformed B cell clones: constitutive and inducible expression of interleukin-4 mRNA.
    Tang H; Matthes T; Carballido-Perrig N; Zubler RH; Kindler V
    Eur J Immunol; 1993 Apr; 23(4):899-903. PubMed ID: 8384561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraperitoneal nitric oxide production in patients treated by continuous ambulatory peritonal dialysis.
    Davenport A; Fernando RL; Varghese Z
    Blood Purif; 2004; 22(2):216-23. PubMed ID: 15044821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammation.
    Zemel D; Krediet RT; Koomen GC; Kortekaas WM; Geertzen HG; ten Berge RJ
    Nephrol Dial Transplant; 1994; 9(2):169-74. PubMed ID: 8190331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serial cytokine changes in peritoneal effluent and plasma during peritonitis in patients on continuous ambulatory peritoneal dialysis (CAPD).
    KozioĊ‚-Montewka M; Ksiazek A; Janicka L; Baranowicz I
    Inflamm Res; 1997 Apr; 46(4):132-6. PubMed ID: 9137991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients.
    Nakahama H; Tanaka Y; Shirai D; Miyazaki M; Imai N; Yokokawa T; Okada M; Kubori S
    Nephron; 1992; 61(2):132-4. PubMed ID: 1630534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients.
    Moutabarrik A; Nakanishi I; Namiki M; Tsubakihara Y
    Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine production by highly purified human CD8+ T cells.
    Li Y; Richards D; Noble A; Kemeny DM
    Int Arch Allergy Immunol; 1995; 107(1-3):354-5. PubMed ID: 7613170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells.
    Laranjeira P; Pedrosa M; Pedreiro S; Gomes J; Martinho A; Antunes B; Ribeiro T; Santos F; Trindade H; Paiva A
    Stem Cell Res Ther; 2015 Jan; 6(1):3. PubMed ID: 25559824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential mRNA expression and production of interleukin-4 and interferon-gamma in stimulated peripheral blood mononuclear cells of house-dust mite-allergic patients.
    Laan MP; Baert MR; Vredendaal AE; Savelkoul HF
    Eur Cytokine Netw; 1998 Mar; 9(1):75-84. PubMed ID: 9613681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and surface expression of ICAM-1 in polymorphonuclear neutrophilic leukocytes in normal subjects and during inflammatory disease.
    Elsner J; Sach M; Knopf HP; Norgauer J; Kapp A; Schollmeyer P; Dobos GJ
    Immunobiology; 1995 Aug; 193(5):456-64. PubMed ID: 8522360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.